TrialBlood2018

Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial.

Nigel Russell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.